<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01659580</url>
  </required_header>
  <id_info>
    <org_study_id>T89-07-CAESA</org_study_id>
    <secondary_id>T89-07-GL</secondary_id>
    <nct_id>NCT01659580</nct_id>
  </id_info>
  <brief_title>Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina</brief_title>
  <acronym>CAESA</acronym>
  <official_title>Phase III Confirmatory Trial to Confirm the Anti-anginal Effect of Dantonic® (T89) in Patients With Chronic Stable Angina</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tasly Pharmaceuticals, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tasly Pharmaceuticals, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This phase III study is designed as a double blind, randomized, multi-nation, multi-center,
      placebo controlled clinical research, which aims to evaluate the safety and efficacy of
      Dantonic® (T89) in patients with chronic stable angina pectoris.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Dantonic® (T89) is a botanical drug consists of extracts of Danshen (Radix Salviae
      Miltiorrhizae) and Sanqi (Radix Notoginseng) with borneol in a capsule form. The drug is
      currently approved in 26 countries outside the USA for the treatment and prevention of
      chronic stable angina pectoris and other cardiovascular disease related conditions. This
      pivotal confirmative Phase III clinical trial is to confirm the efficacy and safety of the
      drug at 150mg and 225mg doses in the prevention and treatment of angina pectoris in patients
      with Chronic Stable Angina. The contribution of the main herb Danshen to, and the difference
      of various production batches in, the overall efficacy and safety profiles will also be
      explored. Patients will take a morning and an evening dose orally (every 12 hours) for 6
      weeks while stop taking any long-acting nitroglycerin, ranolazine, and/or multiple
      beta-blockers or beta blocker(s) with calcium channel blocker during the trial. Single
      beta-blocker and/or on-demand short acting nitroglycerin to relief angina pectoris is allowed
      during the trial. After physical exams and if eligible to participation, patients will stop
      taking other drugs, and undergo two baseline screen Exercise Treadmill Tests (ETT) on
      Standard Bruce Protocol in the clinic one week before and right before starting the drug
      treatment. Patients will perform three more ETTs before the morning dose at the end of week
      2, 4 and 6 after receiving the drug treatment. The primary efficiency endpoint is the change
      of symptom-limited Total Exercise Duration of the ETT at the end of the 4th week of treatment
      from the average of the two screening baselines compared with that of placebo treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The change of symptom-limited TED from baseline compared to placebo at the end of week 4.</measure>
    <time_frame>4 weeks</time_frame>
    <description>The change of symptom-limited Total Exercise Duration (TED) at trough drug levels at the end of the 4th week of treatment from screen baseline on Standard Bruce Protocol compared with placebo.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The change of symptom-limited TED at trough drug levels at the end of the 2nd and 6th weeks</measure>
    <time_frame>2nd weeks and 6th weeks</time_frame>
    <description>The change of symptom-limited TED at trough drug levels at the end of the 2nd and 6th weeks of treatment from screen baseline on Standard Bruce Protocol compared with placebo;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of weekly angina episodes</measure>
    <time_frame>6 weeks</time_frame>
    <description>Frequency of weekly angina episodes</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Time to onset of angina during Excise Tolerance Test (ETT);</measure>
    <time_frame>6 weeks</time_frame>
    <description>Time to onset of angina during ETT;</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">1004</enrollment>
  <condition>Angina Pectoris</condition>
  <arm_group>
    <arm_group_label>T89 high dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>T89 225mg bid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>T89 low dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>T89 150mg bid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sanqi+Bingpian</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>225mg bid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>225mg bid</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>T89 high dose</intervention_name>
    <description>225mg bid</description>
    <arm_group_label>T89 high dose</arm_group_label>
    <other_name>Dantonic®</other_name>
    <other_name>Compound Danshen Dripping Pills</other_name>
    <other_name>Salvtonic®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>T89 Low dose</intervention_name>
    <description>150mg bid</description>
    <arm_group_label>T89 low dose</arm_group_label>
    <other_name>Dantonic®</other_name>
    <other_name>Salvtonic®</other_name>
    <other_name>Compound Danshen Dripping Pill</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sanqi+Bingpian</intervention_name>
    <description>225 mg bid</description>
    <arm_group_label>Sanqi+Bingpian</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>225mg bid</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Written informed consent.

          2. Males and females between the ages of 20 and 80 years.

          3. Females of childbearing potential must have a negative pregnancy test, not be breast
             feeding and established on a method of contraception that in the investigator's
             opinion is acceptable. Females must agree to remain on their established method of
             contraception through their participation in the study and for 14 days following the
             last dose of study drug.

          4. Evidence of coronary artery disease that consists of a well-documented medical history
             (over 3 months prior to the enrolment) of myocardial infarction or significant
             coronary artery disease with noninvasive or angiographic confirmation.

          5. Symptoms that support the diagnosis of chronic angina and/or a history of an abnormal
             exercise response limited by angina and/or electrocardiograph (ECG) changes.

          6. Moderate angina pectoris (Class II or III, Grading of Angina Pectoris by the Canadian
             Cardiovascular Society Classification System).

          7. Patient whose symptom-limited Total Exercise Duration (TED) is between 3 to 7 minutes
             in Exercise Tolerance Test (ETT) on Standard Bruce Protocol, and symptom-limited TED
             on two screen examinations (Day -7 and 0) in which the shorter is within 85% of the
             longer .

          8. Patient has been on one beta-blocker or on one calcium-channel blocker for at least 14
             days prior to dosing of study medication and can remain on this treatment throughout
             the study as background anti-anginal treatment. Short-acting nitroglycerin for
             on-demand use is allowed for all eligible patients.

          9. Understand and be willing, able and likely to comply with all study procedures and
             restrictions and comprehends the verbal rating scales and diary cards.

        Exclusion Criteria:

          1. With contraindication to, unable to, or with other co-morbidities that may prevent or
             interfere with the ability to perform treadmill ETT (including, but not limited to:
             pulmonary hypertension, functionally limiting COPD (chronic obstructive pulmonary
             disease), history of pulmonary tuberculosis, prior hospitalization for acute
             exacerbation of chronic lung disease, home oxygen use, chronic oral steroid therapy
             that can limit exercise capacity, functionally limiting peripheral artery disease,
             etc.).

          2. Presence of electrocardiographic or other abnormalities/factors that could interfere
             with exercise electrocardiograph interpretation or may lead to a false positive stress
             test (e.g., pre-exercise horizontal or down-sloping ST segment depression in any
             standard lead, cardiac glycoside therapy, Lown-Ganong-Levine Syndrome,
             Wolff-Parkinson-White syndrome (WPW), left bundle branch block, left ventricular
             hypertrophy with repolarization abnormality, implanted pacemaker, etc.).

          3. Clinically significant arrhythmias or atrioventricular conduction block greater than
             first degree, decompensated heart failure, atrial fibrillation, hypertrophic
             cardiomyopathy.

          4. Acute coronary syndrome (acute myocardial infarction or unstable angina) in the prior
             2 months or coronary revascularization within the prior 6 months or planned coronary
             revascularization during the study period.

          5. Congenital cardiac defects, ongoing history of decompensated congestive heart failure,
             severe valvular disease, severe uncontrolled hypertension (seated systolic blood
             pressure &gt; 180 mm Hg or diastolic blood pressure &gt; 110 mm Hg), severe anemia,
             suspected or known dissecting aortic aneurysm, acute myocarditis or pericarditis,
             thrombophlebitis or pulmonary embolism.

          6. History of bleeding diathesis, cerebral hemorrhage, or seizure disorders that required
             anticonvulsant medication.

          7. Patients requiring the use of long-acting nitroglycerin, ranolazine, and/or multiple
             anti-anginal drugs.

          8. Aspirin and/or statins started less than 14 days prior to the signing of informed
             consent.

          9. Pregnancy or lactation.

         10. Clinical trials/experimental medication 1) Participation in any other clinical trial
             or receipt of an investigational drug within 30 days prior to the initial visit.

        2) Previous participation in the studies of T89. 11. Substance abuse. Patients with a
        recent history (within the last 2 years) of alcoholism or known drug dependence.

        12. Is a family member or relative of the study site staff. 13. Any other conditions that,
        in the opinion of the investigator, are likely to prevent compliance with the study
        protocol or pose a safety concern if the subject participates in the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Henry He Sun, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Tasly Group, Co. Ltd.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cardiology and Medicine Clinic</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beaver Medical Clinic</name>
      <address>
        <city>Banning</city>
        <state>California</state>
        <zip>92220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Foundation for Cardiovascular Medicine</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Precision Research Institute</name>
      <address>
        <city>National City</city>
        <state>California</state>
        <zip>91950</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Paradigm Clinical Research Institute, Inc.</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harbor-UCLA Medical Center</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90509</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jacksonville Center for Clinical Research</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brevard Cardiovascular Research Associates</name>
      <address>
        <city>Merritt</city>
        <state>Florida</state>
        <zip>32952</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NewPhase Clinical Trials, Inc.</name>
      <address>
        <city>Miami Beach</city>
        <state>Florida</state>
        <zip>33140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SouthCoast Research Center, Inc</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33144</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Molecular Imaging Research and Clinical Trials</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33156</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Integrity Clinical Trials</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33165</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peninsula Research, Inc.</name>
      <address>
        <city>Ormond Beach</city>
        <state>Florida</state>
        <zip>32174</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Center of Sarasota</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jedidiah Clinical Research</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33617</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Athens Heart Center</name>
      <address>
        <city>Athens</city>
        <state>Georgia</state>
        <zip>30606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Atlanta Clinical Research Center</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ellipsis Research</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Cardiology</name>
      <address>
        <city>Campbellsville</city>
        <state>Kentucky</state>
        <zip>42718</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alexandria Cardiology Clinic</name>
      <address>
        <city>Alexandria</city>
        <state>Louisiana</state>
        <zip>71301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tulane University Health Science Center, Tulane University Heart &amp; Vascular Institute</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manhattan Medical Research Practice</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Medina</city>
        <state>Ohio</state>
        <zip>44256</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hillsboro Cardiology, PC</name>
      <address>
        <city>Hillsboro</city>
        <state>Oregon</state>
        <zip>97123</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kore CV Research</name>
      <address>
        <city>Jackson</city>
        <state>Tennessee</state>
        <zip>38305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tennessee Center for Clinical Trials</name>
      <address>
        <city>Tullahoma</city>
        <state>Tennessee</state>
        <zip>37388</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Angiocardiac Care of Texas, PA</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwest Houston Cardiology</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77070</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Center of Houston, PA</name>
      <address>
        <city>Katy</city>
        <state>Texas</state>
        <zip>77450</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwest Heart Center</name>
      <address>
        <city>Tomball</city>
        <state>Texas</state>
        <zip>77375</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Minsk Regional Clinical Hospital</name>
      <address>
        <city>Minsk</city>
        <zip>223041</zip>
        <country>Belarus</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Petr Polasek, MD, Office of</name>
      <address>
        <city>Kelowna</city>
        <state>British Columbia</state>
        <zip>V1Y 1V6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Medical Arts Health Research Group</name>
      <address>
        <city>North Vancouver</city>
        <state>British Columbia</state>
        <zip>V7L 2P7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Victoria Heart Institute Foundation</name>
      <address>
        <city>Victoria</city>
        <state>British Columbia</state>
        <zip>V8R 4R2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dixie Medical Group</name>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <zip>L4W 0C2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bakbak Medicine Professional Corporation</name>
      <address>
        <city>Oshawa</city>
        <state>Ontario</state>
        <zip>L1H 1B9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart Care Research</name>
      <address>
        <city>Oshawa</city>
        <state>Ontario</state>
        <zip>L1J 2J9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Michael's Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5B 1W8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ViaCar Recherche Clinique Inc.</name>
      <address>
        <city>Brossard</city>
        <state>Quebec</state>
        <zip>J4X 1S4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ViaCar Recherche Clinique Inc.</name>
      <address>
        <city>Greenfield Park</city>
        <state>Quebec</state>
        <zip>J4V 2G8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Cardiovasculaire De La Rive-Sud (Ccrs)</name>
      <address>
        <city>Longueuil</city>
        <state>Quebec</state>
        <zip>J4M 2X1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montreal Heart Institute</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H1T 1C8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Sante Cardio MC</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H1T 3Y7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre de Sante et de Services Sociaux de Trois-Rivieres</name>
      <address>
        <city>Trois-Rivieres</city>
        <state>Quebec</state>
        <zip>G8Z 3R9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Universitaire de Cardiologie et de Pneumologie de Quebec</name>
      <address>
        <city>Quebec</city>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The &quot;Unimed Ajara&quot;</name>
      <address>
        <city>Batumi</city>
        <zip>6000</zip>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiological CLinic &quot;Guli&quot; Ltd</name>
      <address>
        <city>Tbilisi</city>
        <zip>0144</zip>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Archangel St. Michael Multiprofile Clinical Hospital</name>
      <address>
        <city>Tbilisi</city>
        <zip>0159</zip>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardio-Reanimation Centre</name>
      <address>
        <city>Tbilisi</city>
        <zip>0159</zip>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emergency Cardiology Center named by Academician G. Chapidze Ltd</name>
      <address>
        <city>Tbilisi</city>
        <zip>0159</zip>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tbilis Heart and vascular clinic Ltd.</name>
      <address>
        <city>Tbilisi</city>
        <zip>0159</zip>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center of Vascular and Heart Diseases Ltd.</name>
      <address>
        <city>Tbilisi</city>
        <zip>0160</zip>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>&quot;Clinic L J&quot; Ltd</name>
      <address>
        <city>Tbilisi</city>
        <zip>4600</zip>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Consultorio Medico de Especialidad</name>
      <address>
        <city>Tijuana</city>
        <state>Baja California</state>
        <zip>22010</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro para el Desarrollo de la Medicina y Asistencia Médica Especializada SC sede Torreon Coahuila</name>
      <address>
        <city>Torreón</city>
        <state>Coahuila</state>
        <zip>27000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiocen de Guadalajara, S.C.</name>
      <address>
        <city>Guadalajara</city>
        <state>Jalisco</state>
        <zip>44160</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Investigación Clínica Chapultepec</name>
      <address>
        <city>Morelia</city>
        <state>Michoacán</state>
        <zip>58260</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro para el Desarollo de la Medicina y de Asistencia Medica Esp. S.C.</name>
      <address>
        <city>Culiacan</city>
        <state>Sinaloa</state>
        <zip>80020</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Central &quot;Dr. Ignacio Morones Prieto&quot;</name>
      <address>
        <city>San Luis Potosí</city>
        <state>SLP</state>
        <zip>78240</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Cardiología de Aguascalientes</name>
      <address>
        <city>Aguascalientes</city>
        <zip>20230</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>OSMO</name>
      <address>
        <city>Oaxaca</city>
        <zip>68000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional Buegetary Healthcare Institution &quot;Cardiological Dispensary&quot;</name>
      <address>
        <city>Ivanovslaya</city>
        <state>Ivanovslaya Obl.</state>
        <zip>153012</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>State Budgetary Healthcare Institution &quot;State Novosibirsk Regional Clinical Hospital&quot;</name>
      <address>
        <city>Novosibirsk</city>
        <state>Russia</state>
        <zip>630087</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional Cardiology Center</name>
      <address>
        <city>Volgograd</city>
        <state>Russia</state>
        <zip>400008</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Smolensk State Medical Academy Of Roszdrav</name>
      <address>
        <city>Smolensk</city>
        <state>Smoleskaya oblast</state>
        <zip>214019</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Federal State Budgetary Institution Research Institution Of Cardiology Of Sibirsky</name>
      <address>
        <city>Tomsk</city>
        <state>Tomskaya Obl.</state>
        <zip>634012</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ural Medical Academy</name>
      <address>
        <city>Ekaterinburg</city>
        <zip>620036</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nonstate Healthcare Institution &quot;Departmental Clinical Hospital on Kemerovo Station of Public Corporation &quot;Russian Railroad&quot;</name>
      <address>
        <city>Kemerovo</city>
        <zip>650055</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krasnodar regional hospital #1 n.a. Prof. Ochapovskiy S.V.</name>
      <address>
        <city>Krasnodar</city>
        <zip>350086</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Moscow State Healthcare Institution, City Clinical Hospital #15</name>
      <address>
        <city>Moscow</city>
        <zip>111539</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>First Moscow State Medical University</name>
      <address>
        <city>Moscow</city>
        <zip>119991</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Almazov Federal Heart, Blood And Endocrinology Centre</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>197341</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City Polyclinic # 109</name>
      <address>
        <city>St. Petersburg</city>
        <zip>192288</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City Hospital #38 named after Semashko N.A.</name>
      <address>
        <city>St. Petersburg</city>
        <zip>196601</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Almazov Federal Heart, Blood And Endocrinology Centre</name>
      <address>
        <city>St. Petersburg</city>
        <zip>197341</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Petersburg State Health Care, Institution Pokrovskaya City Hospital</name>
      <address>
        <city>St. Petersburg</city>
        <zip>199106</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tyumen Cardiology Center</name>
      <address>
        <city>Tyumen</city>
        <zip>625026</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City Hospital #4</name>
      <address>
        <city>Vladimir</city>
        <zip>600020</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Hospital n.a. N.V. Solovyov</name>
      <address>
        <city>Yaroslavl</city>
        <zip>150003</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional medical center of cardiovascular diseases</name>
      <address>
        <city>Zaporizhzhya</city>
        <state>Zaporizhzhya region</state>
        <zip>69005</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of internal diseases #2</name>
      <address>
        <city>Zaporizhzhya</city>
        <state>Zaporizhzhya region</state>
        <zip>69118</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ivano-Frankivsk Regional Clinical Cardiology Dispensary, department of anesthesiology with intensive care unit</name>
      <address>
        <city>Ivano-Frankivsk</city>
        <zip>76018</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>L.T. Malaya Therapy Institute of National Academy of Medical Sciences of Ukraine, Head of Cardiopulmonology Department Government Institution</name>
      <address>
        <city>Kharkiv</city>
        <zip>61039</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>L.T. Malaya Therapy Institute of National Academy of Medical Sciences of Ukraine</name>
      <address>
        <city>Kharkiv</city>
        <zip>61039</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute Of Gerontology, Department Of Clinical Physiology And Pathology Of Internal Organs</name>
      <address>
        <city>Kiev</city>
        <zip>04114</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kyiv Oleksandrivska Clinical Hospital</name>
      <address>
        <city>Kiev</city>
        <zip>1601</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Municipal Clinical Hospital #1</name>
      <address>
        <city>Kiev</city>
        <zip>2091</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National medical university named after O.O.Bogomolets</name>
      <address>
        <city>Kiev</city>
        <zip>4050</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lviv Regional State Clinical Threatment-and-Diagnostic Cardiology Center</name>
      <address>
        <city>Lviv</city>
        <zip>79015</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Family Medicine and General Practice of Odessa National Medical University</name>
      <address>
        <city>Odessa</city>
        <zip>65010</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City Clinical Hospital No. 3</name>
      <address>
        <city>Odessa</city>
        <zip>65014</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Odessa regional cardiological dispensary</name>
      <address>
        <city>Odessa</city>
        <zip>65025</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>District Clinical Hospital Of Station &quot;Uzhgorod&quot;, Dgto &quot;Lviv Railway Station&quot; Therapeutic Department</name>
      <address>
        <city>Uzhgorod</city>
        <zip>88000</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City Clinical Hospital # 1</name>
      <address>
        <city>Vinnitsa</city>
        <zip>21029</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vinnytsya Regional Specialized Center for Radiation Protection of People</name>
      <address>
        <city>Vinnytsya</city>
        <zip>21018</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belarus</country>
    <country>Canada</country>
    <country>Georgia</country>
    <country>Mexico</country>
    <country>Russian Federation</country>
    <country>Ukraine</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Australia</country>
    <country>Japan</country>
  </removed_countries>
  <link>
    <url>http://www.tasly.com</url>
    <description>manufacture and sponsor</description>
  </link>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 19, 2012</study_first_submitted>
  <study_first_submitted_qc>August 5, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2012</study_first_posted>
  <last_update_submitted>March 7, 2017</last_update_submitted>
  <last_update_submitted_qc>March 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Angina Pectoris Treatment Prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Angina Pectoris</mesh_term>
    <mesh_term>Angina, Stable</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

